ApprovalTrail

Approval · Notice of Compliance 495 · 2002

FLUCONAZOLE: Notice of Compliance 495

Issued December 6, 2002

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
495
Date
December 6, 2002
Company
Pharmel Inc.Montreal, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Admin
Reason
New manufacturer and product name
Therapeutic class
Antifungal agent
Canadian reference product
DIFLUCAN 150 (Pfizer Canada Ulc)

Products in this notice

BrandDINStatus today
FLUCONAZOLE02246942Cancelled Pre Market

Medicinal ingredients